Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Head & Neck 1

Conditions

Neoplasms 1Mucositis 1Head and Neck Neoplasms 1

Interventions

Radiotherapy 7Cisplatin 6Fibroblast Growth Factor 7 3Water 2Radiation 2Low-Level Light Therapy 2Injections 2peppermint oil 1pegfilgrastim 1oxycodone-acetaminophen 1kang-lai-te 1cyclohexaneacetic acid 1brilacidin 1anise oil 1acetaminophen, hydrocodone drug combination 1Xylitol 1Tramadol 1Therapeutics 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Sorbic Acid 1Selenomethionine 1Saline Solution 1RRx-001 1Poloxamer 1Phosphatidylinositol 3-Kinases 1Pain Management 1Neck Dissection 1Methods 1Ketamine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Mucositis × kang-lai-te × Clear all
NCT03101514 2021-06-23

Kanglaite Reduce the Toxicity of Radiotherapy of Head and Neck Cancer Phase II Study

First Affiliated Hospital of Harbin Medical University

Phase 2 Completed
53 enrolled 11 charts
Head & NeckOther

Head and Neck Neoplasms, Neoplasms, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡